Wednesday, November 29, 2023

News

Pfizer, BioNTech COVID-19 vaccine grabs emergency FDA OK

Just over 24 hours after an FDA advisory panel recommended emergency use of Pfizer and BioNTech’s COVID-19 vaccine, the agency followed through, authorizing the first coronavirus pandemic shot for emergency use in the U.S. The FDA...

Panel votes to recommend FDA approval of Pfizer’s COVID-19 vaccine

Late day Thursday, a government advisory panel gave their nods for the use of Pfizer’s COVID-19 vaccine, allowing for the Food and Drug Administration (FDA) to grant the approval for the vaccine. In a 17-4...

New Biomarker may help determine men at higher risk of developing invasive Prostate Cancer

In a published study, in EBio Medicine, researchers at Arizona-based biotech, Aqualung Therapeutics may have identified a novel biomarker that alone, or potentially combined with Prostate-specific antigen (PSA), may determine men who are at higher risk of...

Study: Women face a higher risk for heart failure and heart attack death than men

According to new research published today in the American Heart Association's flagship journal Circulation, women face a 20% increased risk of developing heart failure or dying within five years after their first severe heart attack compared with...

Moderna applies for FDA authorization for its Covid-19 vaccine

Moderna today announced that the primary efficacy analysis of their Phase 3 study of their vaccine candidate, mRNA-1273 conducted on 196 cases confirms the high efficacy observed at the first interim analysis. The data analysis indicates a...

Third COVID-19 vaccine, this one from AstraZeneca, up to 90% effective

A third COVID-19 vaccine, this one from AstraZeneca, reported Monday that late-stage trials showed that its COVID-19 vaccine with Oxford University was up to 90% effective in preventing disease. The results are based on...

FDA Authorizes Monoclonal Antibodies for Treatment of COVID-19

The U.S. Food and Drug Administration issued an emergency use authorization (EUA) for casirivimab and imdevimab to be administered together for the treatment of mild to moderate COVID-19 in adults and pediatric patients with positive results of direct SARS-CoV-2...

Pfizer files with FDA for emergency use of its COVID-19 vaccine in US

Pfizer Inc. and its German partner, BioNTech SE will submit a request today to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of their mRNA vaccine candidate, BNT162b2 against SARS-CoV-2, which will potentially enable...

Pfizer’s COVID-19 shot 95% effective, seeking FDA clearance soon

In a press release issued today, Pfizer said that new test results show its coronavirus vaccine is 95% effective, is safe and also protects older people most at risk of dying — the last data needed to...

Moderna says its COVID-19 vaccine is 94.5% effective

Moderna said its experimental coronavirus vaccine was nearly 95 percent effective in a pivotal study. The NIH-appointed Data Safety Monitoring Board (DSMB) informed Moderna that the trial has met the statistical criteria pre-specified in the study protocol for...
- Advertisement -

Latest News

CEO Corner: Nikole Kimes, CEO & Co-Founder at Siolta Therapeutics

We recently spoke with Nikole Kimes, PhD, CEO and Co-Founder at Siolta Therapeutics, a clinical-stage biopharmaceutical company...
- Advertisement -

Survey shows Americans are sinking money they don’t have into credit cards they can’t pay off – at alarming rates

Quicken Inc., maker of America's best-selling personal finance software, today shared findings from a survey that explored Americans' financial outlook amid the...

Elon Musk says Twitter to change the logo, removes bird logo

Twitter's owner, Elon Musk posted on Sunday that he was looking to change Twitter’s logo, tweeting: “And soon we shall bid adieu...

Turning food waste into bioenergy can become a profitable industry

Food waste is a major problem around the world. In the United States, an estimated 30 to 40% of edible food is lost...

Researchers uncover how a genetic mutation can cause individuals with normal cholesterol levels to develop coronary artery disease at a young age

A novel molecular pathway to explain how a mutation in the gene ACTA2 can cause individuals in their 30s – with normal...